First Tracks Biotherapeutics Inc (TRAX )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol TRAX
- Company First Tracks Biotherapeutics Inc
- Price $36.52
- Changes Percentage 0.84
- Change 0.305
- Day Low $34.76
- Day High $39.67
- Year High $26.8
- Year Low $14.79
- Market Cap $534,551,277
- Price Avg 50 EMA (D) $19.55
- Price Avg 200 EMA (D) $19.55
- Exchange NASDAQ
- Volume 524,396
- Average Volume 399,390
- Open $35.82
- Previous Close $36.21
- EPS -4.71
- PE -3.25
- Earnings Announcement 1970-01-01 00:00:00
- Shares Outstanding $34,892,381
Company brief: FIRST TRACKS BIOTHERAPEUTICS INC (TRAX )
- Healthcare
- Biotechnology
- Daniel R. Faga
- US
- N/A
- 04-20-2026
- US3371851029
First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101. The company is headquartered in San Diego, CA.